Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neos Therapeutics Inc. NEOS

Healthcare Drug Manufacturers - Major
Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The product portfolio of the company includes Methylphenidate XR-ODT and Amphetamine XR oral suspension commonly prescribed medicine for the treatment of ADHD. In... see more

Recent & Breaking News (NDAQ:NEOS)

Neos Therapeutics Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug Candidate, NT-0201, for the Treatment of ADHD

GlobeNewswire November 17, 2016

Neos Therapeutics Reports Third Quarter 2016 Financial Results

GlobeNewswire November 10, 2016

Neos Therapeutics to Present at Stifel 2016 Healthcare Conference

GlobeNewswire November 8, 2016

Neos Therapeutics to Host Third Quarter 2016 Financial Results Conference Call on November 10, 2016

GlobeNewswire November 3, 2016

Robbins Arroyo LLP Is Investigating the Officers and Directors of Neos Therapeutics, Inc. (NEOS) on Behalf of Shareholders

Business Wire November 1, 2016

Johnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics, Inc., KemPharm, Inc., Neos Therapeutics, Inc., CommVault Systems, Inc. and Resource Capital Corp.

PR Newswire October 26, 2016

Lifshitz & Miller Law Firm Announces Investigation of Inteliquent, Inc., Isle of Capri Casinos, Inc., Janus Capital Group, Inc., MGT Capital Investments, Inc., MoneyGram International Inc., Neos Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Twitt

PR Newswire October 10, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Neos Therapeutics, Inc. and Certain Officers and Directors

Business Wire October 7, 2016

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire September 30, 2016

NEOS INVESTOR ALERT: The Law Offices of Vincent Wong Launches Investigation of Neos Therapeutics, Inc. for Possible Securities Fraud Violations

Business Wire September 30, 2016

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire September 21, 2016

NEOS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launch Investigation of Neos Therapeutics, Inc. for Possible Securities Fraud Violations

PR Newswire September 21, 2016

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire September 20, 2016

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire September 19, 2016

INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire September 19, 2016

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Claims against Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire September 15, 2016

NEOS INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Neos Therapeutics, Inc. and Certain Officers and Directors

Business Wire September 15, 2016

Neos Therapeutics to Present at the Wells Fargo Securities Healthcare Conference on September 8, 2016

GlobeNewswire August 31, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  August 29, 2016

Neos Therapeutics Announces Second Quarter 2016 Financial Results

GlobeNewswire August 11, 2016